[{"Assets_0_FY_USD":1046479000.0,"CommonStockSharesOutstanding_0_FY_shares":592072330.0,"EarningsPerShareBasic_1_FY_USD":-0.17,"EarningsPerShareDiluted_1_FY_USD":-0.17,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":12752000.0,"NetIncomeLoss_1_FY_USD":-99323000.0,"NetIncomeLoss_4_FY_USD":-93105000.0,"StockholdersEquity_0_FY_USD":669809000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180228"}]